Vasoplegic syndrome following cardiothoracic surgery—review of pathophysiology and update of treatment options

LW Busse, N Barker, C Petersen - Critical Care, 2020 - Springer
Vasoplegic syndrome is a common occurrence following cardiothoracic surgery and is
characterized as a high-output shock state with poor systemic vascular resistance. The …

Vasoplegic syndrome after cardiovascular surgery: a review of pathophysiology and outcome‐oriented therapeutic management

V Datt, R Wadhhwa, V Sharma, S Virmani… - Journal of cardiac …, 2021 - Wiley Online Library
Background: Vasoplegic syndrome (VPS) is defined as systemic hypotension due to
profound vasodilatation and loss of systemic vascular resistance (SVR), despite normal or …

Vasoplegic syndrome after cardiopulmonary bypass in cardiovascular surgery: Pathophysiology and management in critical care

Z Ltaief, N Ben-Hamouda, V Rancati, Z Gunga… - Journal of Clinical …, 2022 - mdpi.com
Vasoplegic syndrome (VS) is a common complication following cardiovascular surgery with
cardiopulmonary bypass (CPB), and its incidence varies from 5 to 44%. It is defined as a …

[HTML][HTML] Treatment with angiotensin II is associated with rapid blood pressure response and vasopressor sparing in patients with vasoplegia after cardiac surgery: a …

A Klijian, AK Khanna, VS Reddy, B Friedman… - … of Cardiothoracic and …, 2021 - Elsevier
Objective: The present study investigated outcomes in patients with vasoplegia after cardiac
surgery treated with angiotensin II plus standard-of-care vasopressors. Vasoplegia is a …

What's new in cardiopulmonary bypass

EA Hessel II - Journal of cardiothoracic and vascular anesthesia, 2019 - Elsevier
This is a narrative review of recent articles (mainly published in 2017 and 2018) related to
the conduct of cardiopulmonary bypass (CPB) that should be of interest to the cardiac …

Vasoplegia after cardiopulmonary bypass: A narrative review of pathophysiology and emerging targeted therapies

TJ Barnes, MA Hockstein… - SAGE open medicine, 2020 - journals.sagepub.com
Cardiovascular disease remains the leading cause of death in the United States, and
cardiopulmonary bypass is a cornerstone in the surgical management of many related …

Hydroxocobalamin for the treatment of vasoplegia: a review of current literature and considerations for use

AD Shapeton, F Mahmood… - Journal of Cardiothoracic …, 2019 - jcvaonline.com
VASOPLEGIA is a term used to describe hypotension in the setting of high pressor
requirements and normal or increased cardiac output. A commonly used numerical …

Hydroxocobalamin for vasodilatory hypotension in shock: A systematic review with meta analysis for the comparison to methylene blue

HM Brokmeier, TG Seelhammer, SD Nei… - … of Cardiothoracic and …, 2023 - Elsevier
Hydroxocobalamin inhibits nitric oxide-mediated vasodilation and has been used in settings
of refractory shock. However, its effectiveness and role in treating hypotension remain …

Vasoplegia during cardiopulmonary bypass: current literature and rescue therapy options

J Ortoleva, A Shapeton, M Vanneman… - Journal of Cardiothoracic …, 2020 - Elsevier
Vasoplegia syndrome in the cardiac surgical intensive care unit and postoperative period
has been an area of interest to clinicians because of its prevalence and effects on morbidity …

Right ventricular failure after left ventricular assist device placement—the beginning of the end or just another challenge?

KR Turner - Journal of cardiothoracic and vascular anesthesia, 2019 - Elsevier
Left ventricular assist device (LVAD) therapy has greatly improved outcomes in patients with
end-stage heart failure. However, development of right ventricular failure (RVF) in LVAD …